|
시장보고서
상품코드
2132281
미국의 각막굴절교정렌즈 시장 규모, 점유율, 동향 분석 보고서 : 종류별, 질환별, 연령층별, 최종 용도별 및 부문별 예측(2026-2033년)U.S. Orthokeratology Lens Market Size, Share & Trends Analysis Report By Type, By Disease Indication, By Age Group, By End-use, And Segment Forecasts, 2026 - 2033 |
||||||
미국의 각막굴절교정렌즈 시장 요약
미국의 각막굴절교정렌즈 시장 규모는 2025년에 2,950만 달러로 평가되며, 2026년 2,980만 달러에서 2033년까지 3,250만 달러로 확대될 것으로 예상되며, 2026년부터 2033년까지 연평균 성장률(CAGR)은 1.2%에 달할 것으로 예측됩니다.
이러한 수요의 배경으로는 소아 근시 유병률의 증가와 안과 의료 종사자들 사이에서 근거 기반 근시 관리에 대한 중요성이 높아지고 있는 점을 들 수 있습니다.
망막박리, 녹내장,근시성 황반변성, 백내장 등 진행성 근시에 수반되는 장기적인 위험에 대한 인식이 높아짐에 따라, 검안사들은 안경이나 콘택트렌즈를 사용하지 않고 주간 시력을 교정하면서 안축장의 신장을 늦추는 효과적인 중재법으로 오르토케라토지를 점점 더 권장하고 있습니다.
망막 질환에 대한 높은 인식과 확립된 의료 인프라가 첨단 진단 기술의 도입을 촉진하고 있습니다. 'Optometry &Vision Science'지에 최근 게재된 논문에서는 미국 내 오르토케라톨로지의 현황에 관한 주요 동향과 인사이트이 다루어졌습니다. 500명 이상의 안과 의료 전문가(ECP)를 대상으로 실시된 ‘미국 내 오르토케라톨로지 피팅(FOKUS)’ 설문조사 결과에 따르면, 각막굴절교정렌즈 피팅을 적극적으로 실시하고 있는 전문가의 56%가 향후 1년 동안 시장 성장을 예상하고 있는 것으로 나타났습니다. 또한, 현재 이러한 렌즈를 처방하지 않는 안과 의료 전문가의 46%가 향후 2년 이내에 처방을 시작할 계획이라고 응답했습니다.
디지털 기기 사용으로 인한 화면 시청 시간의 증가도 시장 성장에 중요한 역할을 하고 있습니다. 비전 카운슬(Vision Council)의 조사에 따르면, 성인의 60% 이상이 디지털 눈 피로 증상을 경험하고 있는 것으로 보고되었으며, 이로 인해 눈 관리와 효과적인 시력 교정법의 중요성에 대한 인식이 높아지고 있습니다. 이러한 추세로 인해 더 많은 사람들이 각막굴절교정렌즈를 효과적인 해결책으로 고려하고 있습니다.
또한, 미국 내 오르토케라톨로지에 대한 임상적 수용도가 높아지고 의료 전문가들의 도입이 확대되면서 수요가 더욱 촉진되고 있습니다. ‘미국 내 오르토케라톨로지 피팅(FOKUS)’ 조사에 따르면, 미국 의료 종사자의 약 68%가 주로 근시 관리를 목적으로 오르토케라톨로지를 처방하고 있으며, 56%는 향후 12개월 동안 오르토케라톨로지 피팅 건수가 증가할 것으로 예상하고 있습니다. 또한, 현재 오르토케라톨로지를 제공하지 않는 의료 종사자의 거의 절반이 이 서비스 제공을 시작할 계획이라고 밝혔으며, 이는 제공 기관의 증가와 이 기술에 대한 신뢰도 상승을 반영하고 있습니다. 이러한 추세에 더해, 각막 토포그래피, 맞춤형 렌즈 설계, 디지털 피팅 소프트웨어의 발전으로 인해 오르토케라톨로지는 임상의와 환자 모두에게 더욱 이용하기 쉽고 효율적인 치료법으로 자리 잡고 있습니다.
목차
제1장 조사 방법과 범위
제2장 주요 요약
제3장 미국의 각막굴절교정렌즈 시장 : 변수, 동향, 범위
제4장 미국의 각막굴절교정렌즈 시장 : 유형별 추정·동향 분석
제5장 미국의 각막굴절교정렌즈 시장 : 질환 적응증별 추정·동향 분석
제6장 미국의 각막굴절교정렌즈 시장 : 연령층별 추정·동향 분석
제7장 미국의 각막굴절교정렌즈 시장 : 최종 용도별 추정·동향 분석
제8장 경쟁 구도
KSMU.S. Orthokeratology Lens Market Summary
The U.S. orthokeratology lens market size was valued at USD 29.5 million in 2025 and is projected to grow from USD 29.8 million in 2026 to USD 32.5 million by 2033, at a CAGR of 1.2% from 2026 to 2033. The demand is attributed to the growing prevalence of pediatric myopia and the increasing emphasis on evidence-based myopia management among eye care professionals.
As awareness grows regarding the long-term risks associated with progressive myopia, including retinal detachment, glaucoma, myopic macular degeneration, and cataracts, optometrists are increasingly recommending orthokeratology as an effective intervention to slow axial elongation while providing daytime vision correction without glasses or contact lenses.
High awareness of retinal disorders and an established healthcare infrastructure facilitate the adoption of advanced diagnostic technologies. A recent paper published in Optometry & Vision Science highlights key trends and insights regarding the current state of orthokeratology in the U.S. The findings from the Fitting of Orthokeratology in the United States (FOKUS) survey, conducted with over 500 eye care professionals (ECPs), reveal that 56% of those actively fitting ortho-k lenses expect market growth in the coming year. In addition, 46% of ECPs not currently fitting these lenses plan to begin prescribing them within the next two years.
The increase in screen time due to digital devices also plays a crucial role in market growth. A study by the Vision Council reported that over 60% of adults experience symptoms of digital eye strain, leading to heightened awareness regarding eye care and the importance of effective vision correction methods. This trend is driving more individuals to consider ortho-K lenses as a viable solution.
Demand is also being driven by increasing clinical acceptance and practitioner adoption of orthokeratology in the U.S. The Fitting of Orthokeratology in the United States (FOKUS) survey found that approximately 68% of U.S. practitioners prescribe orthokeratology primarily for myopia management, while 56% expect growth in orthokeratology fitting over the following 12 months. In addition, nearly half of practitioners who are not currently offering orthokeratology indicated plans to begin offering the service, reflecting expanding provider availability and growing confidence in the technology. These trends, combined with advancements in corneal topography, customized lens design, and digital fitting software, are making orthokeratology more accessible and efficient for both clinicians and patients.
U.S. Orthokeratology Lens Market Report Segmentation
This report forecasts revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. orthokeratology lens market report based on type, disease indication, age group, and end-use:
- Type Outlook (Revenue, USD Million, 2021 - 2033)
- Spherical
- Toric
- Disease Indication Outlook (Revenue, USD Million, 2021 - 2033)
- Nearsightedness (Myopia)
- Astigmatism
- Others
- Age Group Outlook (Revenue, USD Million, 2021 - 2033)
- 6-12 Years
- 13-19 Years
- 20 Years & Above
- End-use Outlook (Revenue, USD Million, 2021 - 2033)
- Optometry Clinics
- Ophthalmology Clinics
- Hospitals
- Others
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Segment Definitions
- 1.2.1. Type
- 1.2.2. Disease Indication
- 1.2.3. Age Group
- 1.2.4. End Use
- 1.2.5. Country scope
- 1.2.6. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. Disease Indication outlook
- 2.2.3. Age Group outlook
- 2.2.4. End Use outlook
- 2.3. Competitive Insights
Chapter 3. U.S. Orthokeratology Lens Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. U.S. Orthokeratology Lens Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Technological landscape
- 3.3.2.5. Environmental landscape
- 3.3.2.6. Legal landscape
- 3.3.1. Industry Analysis - Porter's
Chapter 4. U.S. Orthokeratology Lens Market: Type Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. U.S. Orthokeratology Lens Market: Type Movement Analysis
- 4.3. U.S. Orthokeratology Lens Market by Type Outlook (USD Million)
- 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
- 4.5. Spherical
- 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6. Toric
- 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Orthokeratology Lens Market: Disease Indication Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. U.S. Orthokeratology Lens Market: Disease Indication Movement Analysis
- 5.3. U.S. Orthokeratology Lens Market by Disease Indication Outlook (USD Million)
- 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
- 5.5. Nearsightedness (Myopia)
- 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6. Astigmatism
- 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.7. Others
- 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. U.S. Orthokeratology Lens Market: Age Group Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. U.S. Orthokeratology Lens Market: Age Group Movement Analysis
- 6.3. U.S. Orthokeratology Lens Market by Age Group Outlook (USD Million)
- 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
- 6.5. 6-12 Years
- 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6. 13-19 Years
- 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.7. 20 Years & Above
- 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. U.S. Orthokeratology Lens Market: End Use Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. U.S. Orthokeratology Lens Market: End Use Movement Analysis
- 7.3. U.S. Orthokeratology Lens Market by End Use Outlook (USD Million)
- 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
- 7.5. Optometry Clinics
- 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6. Ophthalmology Clinics
- 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7. Hospitals
- 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8. Others
- 7.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Market Participant Categorization
- 8.2. Key Company Profiles
- 8.2.1. Euclid Vision Corporation
- 8.2.1.1. Company Overview
- 8.2.1.2. Financial Performance
- 8.2.1.3. Product/Service Benchmarking
- 8.2.1.4. Strategic Initiatives
- 8.2.2. CooperVision
- 8.2.2.1. Company Overview
- 8.2.2.2. Financial Performance
- 8.2.2.3. Product/Service Benchmarking
- 8.2.2.4. Strategic Initiatives
- 8.2.3. Contex, Inc.
- 8.2.3.1. Company Overview
- 8.2.3.2. Financial Performance
- 8.2.3.3. Product/Service Benchmarking
- 8.2.3.4. Strategic Initiatives
- 8.2.4. Bausch + Lomb.
- 8.2.4.1. Company Overview
- 8.2.4.2. Financial Performance
- 8.2.4.3. Product/Service Benchmarking
- 8.2.4.4. Strategic Initiatives
- 8.2.5. Johnson & Johnson
- 8.2.5.1. Company Overview
- 8.2.5.2. Financial Performance
- 8.2.5.3. Product/Service Benchmarking
- 8.2.5.4. Strategic Initiatives
- 8.2.6. Art Optical Contact Lens, Inc.
- 8.2.6.1. Company Overview
- 8.2.6.2. Financial Performance
- 8.2.6.3. Product/Service Benchmarking
- 8.2.6.4. Strategic Initiatives
- 8.2.7. WAVE Contact Lens System
- 8.2.7.1. Company Overview
- 8.2.7.2. Financial Performance
- 8.2.7.3. Product/Service Benchmarking
- 8.2.7.4. Strategic Initiatives
- 8.2.8. TruForm Optics Inc.
- 8.2.8.1. Company Overview
- 8.2.8.2. Financial Performance
- 8.2.8.3. Product/Service Benchmarking
- 8.2.8.4. Strategic Initiatives
- 8.2.9. AccuLens
- 8.2.9.1. Company Overview
- 8.2.9.2. Financial Performance
- 8.2.9.3. Product/Service Benchmarking
- 8.2.9.4. Strategic Initiatives
- 8.2.1. Euclid Vision Corporation
